Sangamo and Novartis partner on gene therapies for autism
The two companies will develop three neurodevelopmental targets, using the former’s zinc-finger technology.
The two companies will develop three neurodevelopmental targets, using the former’s zinc-finger technology.
In return for capital for development and manufacturing scale-up help, Sanofi and GSK agree number of doses of potential COVID-19 vaccine.
US BARDA drafts Fujifilm Diosynth into its vaccine production effort, offering to also accelerate capacity expansion.